Last week, NIH through the NHGRI committed $2.6 million to the Implementing Genomics in Practice (IGNITE) II: Pragmatic Clinical Trials Network.  The plan is that the network will conduct pragmatic clinical trials to measure the clinical utility and cost-effectiveness of genomic medicine interventions; assess approaches for real-world application of genomic medicine in diverse clinical settings; and produce generalizable knowledge on the types of genomic medicine interventions requiring randomized clinical trials and effective methods for conducting them.  IGNITE II will include multiple clinical groups including enhanced diversity clinical groups, and a single Coordinating Center (CC). This FOA invites applications for the Coordinating Center (CC) and runs in parallel with companion FOAs that invite applications for the CGs (RFA-HG-17-008) and the enhanced diversity CGs (RFA-HG-17-009).

Letters of Intent are due by October 3, 2017.  
Full applications are due November 3, 2017.